FindMyKOL
Clinical trialNCT00400738CompletedPhase 2Interventional

The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients

SponsorThe HIV Netherlands Australia Thailand Research CollaborationEnrollment48HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Treatment with only protease inhibitors might benefit HIV patients. Laboratory data have shown that the combination of saquinavir with lopinavir and ritonavir may a good regimen. This study will explore this idea.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • David Burger, PharmD, PhD

    Radboud University Medical Center

    Study Chair
    clinicaltrials.gov ↗
  • David Cooper, MD, PhD

    National Center in HIV Epidemiology and Clinical Research

    Study Chair
    clinicaltrials.gov ↗
  • Joep Lange, MD, PhD

    International Antiviral Therapy Evaluation Center (IATEC), Center for Poverty-related Communicable Diseases, Department of Internal Medicine, Academic Medical Center (AMC), University of Amsterdam (UVA)

    Study Chair
    clinicaltrials.gov ↗
  • Kiat Ruxrunghtam, MD, PhD

    The HIV Netherlands Australia Thailand Research Collaboration

    Principal Investigator
    clinicaltrials.gov ↗
  • Praphan Phanuphak, MD, PhD

    The HIV Netherlands Australia Thailand Research Collaboration

    Study Chair
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Thailand
  • the Hiv Netherlands Australia Thailand Research Collaboration

    Bangkok, Thailand

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Saquinavir →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2004
Primary completion
31 Dec 2006
Completion
31 Dec 2006
Last update posted
5 Apr 2012
Registered enrollment
48
Registry id
NCT00400738
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.